IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | 0.0% | 119 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 119 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 119 | +85.9% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 64 | +14.3% | 0.00% | – |
| Q2 2021 | $2,000 | -97.9% | 56 | -97.3% | 0.00% | -100.0% |
| Q1 2021 | $94,000 | -20.3% | 2,089 | 0.0% | 0.01% | -28.6% |
| Q4 2020 | $118,000 | +19.2% | 2,089 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $99,000 | -21.4% | 2,089 | -2.1% | 0.01% | -22.2% |
| Q2 2020 | $126,000 | +27.3% | 2,133 | +2.1% | 0.01% | +12.5% |
| Q1 2020 | $99,000 | -21.4% | 2,089 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $126,000 | +0.8% | 2,089 | 0.0% | 0.01% | -10.0% |
| Q3 2019 | $125,000 | +6150.0% | 2,089 | +4995.1% | 0.01% | – |
| Q2 2018 | $2,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -66.7% | 41 | -66.9% | 0.00% | -100.0% |
| Q4 2017 | $6,000 | -25.0% | 124 | -22.5% | 0.00% | 0.0% |
| Q3 2017 | $8,000 | +14.3% | 160 | +15.9% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | +133.3% | 138 | +66.3% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 83 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $4,000 | +33.3% | 83 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | -80.0% | 83 | -87.4% | 0.00% | -66.7% |
| Q2 2016 | $15,000 | -72.7% | 660 | -51.7% | 0.00% | -72.7% |
| Q1 2016 | $55,000 | -35.3% | 1,367 | 0.0% | 0.01% | -38.9% |
| Q4 2015 | $85,000 | – | 1,367 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |